Testosterone modulates serum leptin concentrations in a male patient with hypothalamic hypogonadism.
Serial measurements of body mass index (BMI), serum concentrations of testosterone (T), estradiol (E) and leptin (L) were performed before and after gonadotropin (Gn) therapy in an 18-year-old male subject (BMI 25.4 kg/m2) with idiopathic hypothalamic hypogonadism (IHH). We also measured the BMI and serum concentrations of L in 99 age-matched healthy subjects. Serum L correlated significantly with BMI in control subjects (r=0.84, p<0.0001). Baseline serum concentrations of L in our case were markedly high and both T and E were very low, but Gn therapy resulted in a gradual decrease in L and improvement in T and E, finally reaching the control levels of BMI-matched subjects. Our results demonstrate that T is a powerful negative modulator of serum L independent of BMI in conditions associated with low T levels, such as IHH.
Ogura
T
T
Health and Medical Center, Okayama University, Japan. oguogu@cc.okayama-u.ac.jp
Tobe
K
K
Mimura
Y
Y
Otsuka
F
F
Yamauchi
T
T
Imai
A
A
Tsukamoto
C
C
Iwasaki
Y
Y
Matsuura
K
K
D000293:Adolescent; D001823:Body Composition; D015992:Body Mass Index; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000627:therapeutic use; D004958:Estradiol / Q000097:blood; D007987:Gonadotropin-Releasing Hormone; D006801:Humans; D007006:Hypogonadism / Q000097:blood* / Q000188:drug therapy / Q000209:etiology; D007027:Hypothalamic Diseases / Q000150:complications* / Q000188:drug therapy; D020738:Leptin / Q000378:metabolism*; D008297:Male; D008596:Menotropins / Q000008:administration & dosage / Q000627:therapeutic use; D013739:Testosterone / Q000097:blood / Q000494:pharmacology*
D006063:Chorionic Gonadotropin; D020738:Leptin; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D004958:Estradiol; D008596:Menotropins